PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ENSMUSG00000031627.10 | Irf2 | |
ENSMUSG00000018899.18 | Irf1 | |
ENSMUSG00000041515.11 | Irf8 | |
ENSMUSG00000002325.16 | Irf9 | |
ENSMUSG00000025498.16 | Irf7 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Irf7 | mm39_v1_chr7_-_140846328_140846394 | 0.91 | 3.7e-29 | Click! |
Irf1 | mm39_v1_chr11_+_53660834_53660886 | 0.88 | 3.4e-24 | Click! |
Irf9 | mm39_v1_chr14_+_55842002_55842036 | 0.83 | 1.1e-19 | Click! |
Irf8 | mm39_v1_chr8_+_121463090_121463124 | 0.72 | 6.2e-13 | Click! |
Irf2 | mm39_v1_chr8_+_47192767_47192829 | 0.56 | 2.9e-07 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.1 | 533.1 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
2.8 | 97.6 | GO:0042832 | defense response to protozoan(GO:0042832) |
11.5 | 91.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
5.8 | 87.0 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
2.6 | 82.5 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
5.9 | 70.7 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.4 | 68.2 | GO:0051607 | defense response to virus(GO:0051607) |
4.1 | 61.2 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.4 | 60.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
9.5 | 56.9 | GO:0035549 | interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 334.6 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 315.2 | GO:0005829 | cytosol(GO:0005829) |
0.5 | 279.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.4 | 212.3 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
13.7 | 191.3 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.0 | 136.0 | GO:0005576 | extracellular region(GO:0005576) |
0.9 | 129.7 | GO:0016605 | PML body(GO:0016605) |
8.4 | 118.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
9.3 | 74.4 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 70.4 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 372.9 | GO:0003924 | GTPase activity(GO:0003924) |
1.0 | 276.0 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
5.8 | 174.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
5.1 | 96.9 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
6.4 | 95.8 | GO:0046977 | TAP binding(GO:0046977) |
2.8 | 94.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.4 | 90.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
6.4 | 76.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 65.9 | GO:0003677 | DNA binding(GO:0003677) |
0.5 | 63.0 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 127.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.4 | 91.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.4 | 66.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.4 | 55.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
1.1 | 52.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
3.9 | 42.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.0 | 37.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 33.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
2.0 | 31.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 31.6 | PID IL4 2PATHWAY | IL4-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.1 | 448.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
3.7 | 151.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
1.5 | 127.7 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
1.5 | 82.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
4.7 | 80.5 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
5.7 | 68.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
3.4 | 63.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
1.5 | 63.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.9 | 60.6 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
2.7 | 53.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |